Skip to main content
Smart Investors Daily
BlackRock Health Sciences Trust logo

NYSE · BME

BlackRock Health Sciences Trust

Financial Services · Asset Management

$43.06

Up+$0.49 (+1.15%)

Updated Oct 8, 2026, 5:31 AM

SID Score

4.5/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
523.23M
P/E ratio
8.62
Dividend yield
7.30%
52-week range
$37.51 – $46.43
Volume
40.38K
Avg. volume
50.34K

Price performance · BME

BME price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 7, 2026

BME closed at $43.06 after 21 trading sessions, down 2.91% for the selected period.

Last close
$43.06
Period change
-2.91%
Period low
$42.57
Period high
$44.99
Daily close
View OHLC price history
BME OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 7, 2026$42.48$43.22$42.48$43.0640.38K
Oct 6, 2026$42.90$43.125$42.27$42.5756.37K
Oct 5, 2026$43.33$43.50$42.5643$42.8549.68K
Oct 2, 2026$43.71$43.98$43.23$43.3442.52K
Oct 1, 2026$44.09$44.19$43.5517$43.6131.98K
Sep 30, 2026$44.80$44.80$44.13$44.1344.14K
Sep 29, 2026$44.68$44.775$44.168$44.6218.2K
Sep 28, 2026$44.66$44.925$44.5601$44.6343.7K
Sep 25, 2026$44.95$44.95$44.71$44.8427.69K
Sep 24, 2026$44.62$44.98$44.50$44.9821.17K
Sep 23, 2026$45.00$45.145$44.5157$44.6238.98K
Sep 22, 2026$44.47$44.99$44.24$44.9941.35K
Sep 21, 2026$44.48$44.72$44.29$44.5329.19K
Sep 18, 2026$44.82$44.83$44.435$44.4925.95K
Sep 17, 2026$44.67$44.67$44.17$44.5057.95K
Sep 16, 2026$44.26$44.575$44.01$44.3453.67K
Sep 15, 2026$44.10$44.125$43.85$43.9828.28K
Sep 14, 2026$44.47$44.92$44.39$44.4925.67K
Sep 11, 2026$44.47$44.6799$44.20$44.2220.7K
Sep 10, 2026$44.32$44.55$44.00$44.0638.8K
Sep 9, 2026$44.96$44.96$44.26$44.3535.52K

Latest BME news

The latest Smart Investors Daily articles mentioning BME.

BME research

Overview

Company profile and research snapshot.

Company profile

Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.